Skip to main content
Toggle navigation
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Print
Session X: Upfront Treatment of Myeloma
Maintenance Therapy: Should CD38 ab or Bispecifics be Incorporated? Does MRD Inform Type or Duration Maintenance?
Friday, October 20, 2023
10:45 AM – 11:05 AM
ET
Location: Metropolitan East
Speaker(s)
Ajai Chari, MD
UCSF
San Francisco, California, United States